Torres-Ferreira, J., Ramalho-Carvalho, J., Gómez, A., Menezes, F. D., Freitas, R., Oliveira, J., . . . Jerónimo, C. (2017). MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors. BioMed Central.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Torres-Ferreira, Jorge, et al. MiR-193b Promoter Methylation Accurately Detects Prostate Cancer in Urine Sediments and MiR-34b/c or MiR-129-2 Promoter Methylation Define Subsets of Clinically Aggressive Tumors. BioMed Central, 2017.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Torres-Ferreira, Jorge, et al. MiR-193b Promoter Methylation Accurately Detects Prostate Cancer in Urine Sediments and MiR-34b/c or MiR-129-2 Promoter Methylation Define Subsets of Clinically Aggressive Tumors. BioMed Central, 2017.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.